IRB Review of Phase I Healthy Research: Investigator and IRB Perspectives
Timelines are particularly critical in Phase I research involving healthy participants. A site’s institutional review board (IRB) relationship can significantly impact study milestones.
Join our expert panel of IRB members and Phase I research professionals to hear about common pitfalls in Phase I study designs, challenges with IRB submissions, and strategies to help sponsors and sites plan for success.
Learning Objectives:
- Identify common pitfalls in IRB review of Phase I healthy research
- Describe strategies for IRB collaboration and communication
- Outline IRB criteria when reviewing Phase I research involving healthy participants
Moderated By
Robert Romanchuk
BSHS, CIP, CCRC, CRCP
Former IRB Chairperson
Advarra
Presented By
Theresa Cummings
RN, DBA, CCP
Director, Clinical Protocol Office & Sr. Clinical Research Advisor to the Vice Chancellor of Research
UNC Lineberger
Randall Stoltz
MD, CPI, FAAFP
Former Physician Scientist IRB Member
Advarra
Pankaj Desai
PhD
Professor and Director, Drug Development Graduate Program, College of Pharmacy
University of Cincinnati
DATE: June 17, 2021
Time: 1 pm ET | 10 am PT
Duration: 1 hour